Skip to main content

Table 3 Management of patients with severe CAP

From: Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia

 

Historical

Intervention

 

Group

Group

 

n=142 (44.8)

n=175 (55.2)

Monotherapy

21

17

 Amoxicillin, n=

4

2

 Amoxicillin clavulanate, n=

10

5

 Cetotaxime or Ceftriaxone, n=

7

7

 Other, n=

-

3

Combination therapy

121

158

 Amoxicillinc and Ofloxacin, n=

10

0

 Amoxicillin and Ciprofloxacin, n=

1

0

 Amoxicillin clavulanate and Ofloxacin, n=

29

4

 Amoxicillin clavulanate and Ciprofloxacin, n=

11

0

 Cetotaxime or Ceftriaxone and Ofloxacin, n=

49

9

 Cetotaxime or Ceftriaxone and Ciprofloxacin, n=

5

0

 Amoxicillin and Levofloxacin, n=

0

1

 Amoxicillin clavulanate and Levofloxacin, n=

0

12

 Cetotaxime or Ceftriaxone and Levofloxacin, n=

0

115

 Other combination, n=

16

17

  1. Antibiotics delivered according to studied period; historical controls (1995–2000) and current strategies (2005–2010).